These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 32118738

  • 1. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
    Wang J, Yin Y, Shen C, Yin X, Cai Z, Pu L, Fu W, Wang Y, Zhang B.
    Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
    [Abstract] [Full Text] [Related]

  • 2. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
    Qi J, Liu HL, Ren F, Liu S, Shi W, Liu WH, Cai GQ, Liao GQ.
    World J Surg Oncol; 2020 Apr 07; 18(1):70. PubMed ID: 32264886
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Imatinib Treatment for Patients with Unresectable or Recurrent Gastrointestinal Stromal Tumors.
    Ogata K, Kimura A, Nakazawa N, Suzuki M, Yanoma T, Ubukata Y, Iwamatsu K, Kogure N, Yanai M, Kuwano H.
    Digestion; 2018 Apr 07; 97(1):20-25. PubMed ID: 29393163
    [Abstract] [Full Text] [Related]

  • 4. The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    Yang W, Liu Q, Lin G, Zhang B, Cao H, Zhao Y, Xia L, Feng F, Xiong Z, Hu J, Ye Y, Tao K, Zhang P.
    J Surg Oncol; 2021 Dec 07; 124(7):1128-1135. PubMed ID: 34324197
    [Abstract] [Full Text] [Related]

  • 5. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS).
    Rubió-Casadevall J, Martinez-Trufero J, Garcia-Albeniz X, Calabuig S, Lopez-Pousa A, Del Muro JG, Fra J, Redondo A, Lainez N, Poveda A, Valverde C, De Juan A, Sevilla I, Casado A, Andres R, Cruz J, Martin-Broto J, Maurel J, Spanish Group for Research on Sarcoma (GEIS).
    Ann Surg Oncol; 2015 Sep 07; 22(9):2948-57. PubMed ID: 25608769
    [Abstract] [Full Text] [Related]

  • 6. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
    Cavnar MJ, Wang L, Balachandran VP, Antonescu CR, Tap WD, Keohan M, Singer S, Temple L, Nash GM, Weiser MR, Guillem JG, Aguilar JG, DeMatteo RP, Paty PB.
    Ann Surg Oncol; 2017 Dec 07; 24(13):3972-3980. PubMed ID: 29058144
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C, Chen H, Yin Y, Chen J, Zhang B, Chen Z, Chen J.
    Clinics (Sao Paulo); 2014 Nov 07; 69(11):758-62. PubMed ID: 25518034
    [Abstract] [Full Text] [Related]

  • 9. Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study.
    Sun X, Lin X, Zhang Q, Li C, Shu P, Gao X, Shen K.
    Cancer Med; 2024 Sep 07; 13(18):e70237. PubMed ID: 39300931
    [Abstract] [Full Text] [Related]

  • 10. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
    Tang S, Yin Y, Shen C, Chen J, Yin X, Zhang B, Yao Y, Yang J, Chen Z.
    World J Surg Oncol; 2017 Apr 11; 15(1):79. PubMed ID: 28399894
    [Abstract] [Full Text] [Related]

  • 11. Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10  cm: A Single-Institution Experience in China.
    Shen C, Chen H, Yin Y, Chen J, Tang S, Zhang B, Han L, Chen Z, Chen J.
    Medicine (Baltimore); 2015 Jul 11; 94(28):e1117. PubMed ID: 26181546
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T, Togawa T, Onishi K, Iida A, Sato Y, Goi T.
    J Investig Med High Impact Case Rep; 2020 Jul 11; 8():2324709620970736. PubMed ID: 33228387
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib.
    Chang SC, Liao CH, Wang SY, Tsai CY, Chiang KC, Cheng CT, Yeh TS, Chen YY, Ma MC, Liu CT, Yeh CN.
    Medicine (Baltimore); 2015 Jun 11; 94(24):e1014. PubMed ID: 26091448
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH.
    Eur J Surg Oncol; 2013 Feb 11; 39(2):150-5. PubMed ID: 23084087
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
    Cavnar MJ, Seier K, Gönen M, Curtin C, Balachandran VP, Tap WD, Antonescu CR, Singer S, DeMatteo RP.
    J Gastrointest Surg; 2021 Jul 11; 25(7):1828-1836. PubMed ID: 33169327
    [Abstract] [Full Text] [Related]

  • 19. Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients.
    Xu J, Ling TL, Wang M, Zhao WY, Cao H.
    Int Surg; 2015 May 11; 100(5):860-9. PubMed ID: 26011207
    [Abstract] [Full Text] [Related]

  • 20. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.
    Ann Surg Oncol; 2007 Jan 11; 14(1):14-24. PubMed ID: 17072676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.